T1	CHEM 59 102	vacuna antigripal tetravalente recombinante
T2	CHEM 104 108	RIV4
T3	LIVB 113 126	participantes
T4	Age 127 141	de 9 a 49 años
T5	PHYS 164 179	Inmunogenicidad
T6	CHEM 198 241	vacuna antigripal tetravalente recombinante
T7	CHEM 243 247	RIV4
T8	LIVB 252 257	niños
#1	AnnotatorNotes T8	C0008059; Child; Age Group | C0870221; Boys; Age Group
T9	Age 252 257	niños
T10	LIVB 260 272	adolescentes
#2	AnnotatorNotes T10	C0205653; Adolescent (age group); Age Group
T11	Age 260 272	adolescentes
T12	Age 273 287	de 9 a 17 años
T13	LIVB 290 297	adultos
#3	AnnotatorNotes T13	C0001675; Adult; Age Group
T14	Age 290 297	adultos
T15	Age 298 313	de 18 a 49 años
T16	DISO 337 342	Gripe
#4	AnnotatorNotes T16	C0021400; Influenza; Disease or Syndrome
T17	Age 377 391	de 9 a 49 años
T18	LIVB 423 435	participante
T19	Neg_cue 477 479	no
T20	PHYS 485 495	embarazada
#5	AnnotatorNotes T20	C0032961; Pregnancy; Organism Function
T21	Negated 485 495	embarazada
T22	PHYS 498 506	lactando
#6	AnnotatorNotes T22	C0006147; Breast Feeding; Organism Function
T23	Neg_cue 560 562	No
T24	PHYS 582 590	concebir
#7	AnnotatorNotes T24	C0009637; Conception; Organism Function
T25	Negated 582 590	concebir
T26	Neg_cue 618 620	no
T27	PHYS 640 648	concebir
#8	AnnotatorNotes T27	C0009637; Conception; Organism Function
T28	Negated 640 648	concebir
T29	LIVB 654 659	mujer
#9	AnnotatorNotes T29	C0043210; Woman; Population Group | C0242665; wife; Family Group
T30	PHYS 669 682	premenárquica
T31	PHYS 684 698	posmenopáusica
#10	AnnotatorNotes T31	C0206159; Postmenopause; Organism Function
T32	Duration 707 721	al menos 1 año
T33	PROC 744 769	esterilización quirúrgica
T34	PHYS 794 802	concebir
#11	AnnotatorNotes T34	C0009637; Conception; Organism Function
T35	PROC 820 841	método anticonceptivo
#12	AnnotatorNotes T35	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T36	PROC 864 875	abstinencia
T37	Duration 884 902	al menos 4 semanas
T38	PROC 923 937	administración
#13	AnnotatorNotes T38	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T39	PROC 944 956	intervención
#14	AnnotatorNotes T39	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T40	Duration 975 997	por lo menos 4 semanas
T41	PROC 1019 1033	administración
#15	AnnotatorNotes T41	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T42	PROC 1040 1052	intervención
#16	AnnotatorNotes T42	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T43	LIVB 1072 1084	participante
T44	PROC 1134 1158	consentimiento informado
#17	AnnotatorNotes T44	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T45	LIVB 1214 1219	padre
#18	AnnotatorNotes T45	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T46	LIVB 1223 1228	madre
#19	AnnotatorNotes T46	C0026591; Mother (person); Family Group
T47	LIVB 1236 1255	representante legal
T48	PROC 1287 1311	consentimiento informado
#20	AnnotatorNotes T48	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T49	Neg_cue 1340 1351	Se excluirá
T50	LIVB 1370 1383	participantes
T51	Negated 1370 1383	participantes
T52	DISO 1435 1474	Inmunodeficiencia congénita o adquirida
T53	Speculated 1435 1452	Inmunodeficiencia
T54	Spec_cue 1487 1497	sospechada
T55	PROC 1514 1538	terapia inmunosupresoras
T56	PROC 1545 1558	quimioterapia
#21	AnnotatorNotes T56	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T57	PROC 1561 1587	radioterapia anticancerosa
T58	Duration 1592 1611	los últimos 6 meses
T59	PROC 1615 1649	terapia con corticoides sistémicos
T60	Route 1639 1649	sistémicos
T61	Date 1650 1664	de largo plazo
T62	CHEM 1666 1676	prednisona
#22	AnnotatorNotes T62	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T63	Duration 1699 1728	más de 2 semanas consecutivas
T64	Duration 1732 1754	los 3 meses anteriores
T65	DISO 1760 1787	Hipersensibilidad sistémica
T66	CHEM 1835 1841	vacuna
#23	AnnotatorNotes T66	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T67	DISO 1860 1870	reacciones
#24	AnnotatorNotes T67	C0221736; Reaction emotional; Finding
T68	PROC 1905 1919	administración
#25	AnnotatorNotes T68	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T69	CHEM 1927 1934	vacunas
#26	AnnotatorNotes T69	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T70	CHEM 1968 1974	vacuna
#27	AnnotatorNotes T70	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T71	DISO 2027 2042	Trombocitopenia
#28	AnnotatorNotes T71	C0040034; Thrombocytopenia; Disease or Syndrome
T72	DISO 2047 2070	Trastornos hemorrágicos
#29	AnnotatorNotes T72	C0019087; Hemorrhagic Disorders; Disease or Syndrome
T73	PROC 2073 2087	administración
#30	AnnotatorNotes T73	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T74	CHEM 2091 2106	anticoagulantes
#31	AnnotatorNotes T74	C0003280; Anticoagulants; Pharmacologic Substance
T75	Duration 2110 2123	las 3 semanas
T76	PROC 2188 2212	vacunación intramuscular
T77	Contraindicated 2188 2198	vacunación
T78	Route 2199 2212	intramuscular
T79	LIVB 2235 2247	investigador
#32	AnnotatorNotes T79	C0035173; Research Personnel; Professional or Occupational Group
T80	DISO 2292 2318	síndrome de Guillain-Barré
#33	AnnotatorNotes T80	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T81	DISO 2320 2323	GBS
#34	AnnotatorNotes T81	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T82	DISO 2356 2405	retraso clínicamente significativo del desarrollo
T83	LIVB 2420 2432	investigador
#35	AnnotatorNotes T83	C0035173; Research Personnel; Professional or Occupational Group
T84	DISO 2438 2459	trastorno neurológico
#36	AnnotatorNotes T84	C0027765; nervous system disorder; Disease or Syndrome
T85	DISO 2465 2485	trastorno convulsivo
#37	AnnotatorNotes T85	C0014544; Epilepsy; Disease or Syndrome | C0234972; Convulsive disorder; Disease or Syndrome
T86	Neg_cue 2494 2496	no
T87	Negated 2548 2577	todos los aspectos relevantes
T88	Spec_cue 2586 2593	posible
T89	Speculated 2594 2607	participación
T90	LIVB 2614 2622	paciente
#38	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T91	PROC 2629 2644	estudio clínico
#39	AnnotatorNotes T91	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
